This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

For Inflectra® (infliximab) Prescribing Information for Great Britain click here.
For Inflectra® (infliximab) Prescribing Information for Northern Ireland click here
Adverse event reporting information can be found at the bottom of the page.

Infliximab mechanism of action

Watch how infliximab blocks the funtional activity of TNF-a

Explore more

Inflammatory bowel diseasse

Find out more about Inflectra for your patients with UC and CD.

Learn more

PP-IFA-GBR-0494. September 2021

Quick Links

  • Biosimilars

  • Inflammatory bowel disease

  • Support & Resources

Listen to KOLs discuss treatment optimisation with Inflectra, to help your patients have the most effective treatment possible.

Find out more

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020